Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 25, 2011. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 350,000 Ordinary shares of 25 pence each.
- Purchase Date: October 25, 2011.
- Price Range: Highest price paid was 1,394.5 pence per share; lowest price paid was 1,372.5 pence per share.
- Treasury Holdings (Settled): 508,361,370 shares (9.12% of total issued share capital).
- Treasury Holdings (Including Unsettled): 509,064,248 shares (10.05% of current total voting rights).
- Shares in Issue (Excluding Treasury): 5,062,811,382 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the repurchase of 350,000 shares. Consequently, the percentage of shares held in Treasury increased to 10.05% of total voting rights when including unsettled purchases. The filing does not provide comparative financial data for prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities. No specific risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the total number of shares in issue (5,062,811,382) for calculating disclosure thresholds under Financial Services Authority rules.
- Confirm the current percentage of voting rights held in Treasury (10.05% including unsettled shares).
- Review the price paid per share (1,372.5 to 1,394.5 pence) against market prices on October 25, 2011.
- Note that this filing does not contain operational or financial performance metrics; refer to Form 20-F for comprehensive financial data.